This is a news story, published by Yahoo, that relates primarily to Gavi news.
For more Gavi news, you can click here:
more Gavi newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
global vaccine group Gavi. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccines news, global health emergency news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
mpox vaccineReuters
•79% Informative
Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot.
In 2024 , there have been more than 25,000 suspected mpox cases and 723 deaths in Africa .
Gavi , a public-private alliance which co-funds vaccine purchases for low-income countries, said it will spend up to $50 million .
VR Score
90
Informative language
97
Neutral language
61
Article tone
formal
Language
English
Language complexity
51
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links